Novel α-Microspheres Potentiate Radioembolization for Liver Cancer via Synergistic Vascular Disruption and Self-Powered Cerenkov Photodynamic Therapy
Transarterial radioembolization (TARE) with β-emitting microspheres such as 90 Y serves as standard palliative care for advanced hepatocellular carcinoma (HCC), yet embolism-triggered intratumoral hypoxia confers radioresistance and limits therapeutic efficacy. Unlike β-rays, α-particles possess ultra-high linear energy transfer (LET) and oxygen-independent cytotoxicity, allowing efficient elimination of hypoxic tumor cells. Herein, we fabricated α-emitting 223 Ra-labeled chitosan/calcium phosphate microspheres (denoted 223 Ra-Chi/CaP MS). Capitalizing on the potent hypoxia-insensitive cytotoxicity of α-particles, these microspheres eradicate perivascular tumor cells and disrupt tumor vascular endothelium. To further eliminate tumor cells located distally from the vasculature, the microspheres were loaded with the photosensitizer methylene blue (MB) to harness Cerenkov photons emitted from the 223 Ra decay chain and achieve Cerenkov radiation-induced photodynamic therapy (CR-PDT), thereby expanding the therapeutic reach. The resulting 223 Ra-Chi/CaP-MB MS exhibited excellent physicochemical stability, sustained MB release, and prolonged tumor retention following hepatic artery delivery. In vitro studies demonstrated that the synergistic action of 223 Ra and CR-PDT triggered extensive DNA double-strand breaks and robust ROS generation, leading to enhanced apoptosis even under hypoxic conditions. In a rat orthotopic liver tumor model, TARE using 223 Ra-Chi/CaP-MB MS exerted more potent tumor growth inhibition than embolization controls or plain 223 Ra-Chi/CaP MS, predominantly through disrupting tumor blood vessels, blocking compensatory angiogenesis, and triggering extensive tumor cell apoptosis. With confirmed biosafety, this 223 Ra-based microsphere platform represents a transformative strategy to revitalize TARE for β-refractory liver cancer.
Authors
- 李闻捷
- Jinming Tian
- Yelin WU
- Jiaojiao Li
- Tongyao Hu (ORCID: https://orcid.org/0000-0002-2975-0900)
- Qifan Xu (ORCID: https://orcid.org/0000-0002-7155-9552)
- Yuqiao Wang
- Xiao Li
- Changjing Zuo
- Weiwei Su
- Tao Wang
- Chao Cheng
Institutions
- Tongji University (CN)
- Xuzhou Medical College (CN)
- Second Military Medical University (CN)
- Chinese Academy of Sciences (CN)
- Shanghai East Hospital (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-18
- DOI
- https://doi.org/10.21203/rs.3.rs-11636697/v1
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- preprint
Funders
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Major Research Plan